WALTHAM, Mass. & SAN DIEGO, January 13, 2025--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for ...

Fapon, a global leading life sciences company, is showcasing its comprehensive one-stop IVD solutions and sharing the latest ...

The global IVD contract manufacturing market is on a strong growth trajectory, with a projected market valuation of USD 14.7 billion in 2024, anticipated to increase to an impressive USD 46 billion by ...

and as an in vitro diagnostic (IVD) in regions that accept CE markings as valid regulatory clearance. Co-Diagnostics has also completed the principal design work and in silico analysis of an H5N1 ...

Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., ...